Skip to content
PubMed This is a summary of 82 peer-reviewed journal articles Updated
Immunology · Immunodeficiency 99

Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias: A Patient Guide

At a Glance

Immunodeficiency 99 is a rare genetic immune disorder that can cause both low protective antibodies, leading to recurrent infections, and immune attacks on red blood cells or platelets. Care often combines immunoglobulin replacement, immune-calming medicines, and close monitoring.

Immunodeficiency 99 (IMD99) is an ultra-rare genetic condition that places the immune system in a state of constant conflict. In a healthy body, the immune system acts like a precision security team, distinguishing between dangerous germs and the body’s own healthy cells. In IMD99, this system is affected by an “Inborn Error of Immunity,” meaning the genetic instructions for building that security team are slightly different from the start [1]. This leads to a complex dual challenge: the immune system is simultaneously underactive when it should be defending you and overactive when it should be at rest [2].

What This Guide Can and Cannot Do

Treatment decisions depend on the person’s confirmed gene, current blood counts, infection history, age, pregnancy status, and medicines. Always use a named contact pathway established with your doctor for urgent symptoms.

This paradox is most clearly seen in the two main features of the condition: hypogammaglobulinemia and autoimmune cytopenias. Hypogammaglobulinemia means the body struggles to produce enough protective antibodies, leaving you more vulnerable to recurrent infections in the lungs, sinuses, and gut [3]. At the same time, the immune system may mistakenly identify your own red blood cells or platelets as threats and begin to destroy them [4]. Understanding that these two issues—low defense and high self-attack—can come from the same underlying genetic “glitch” is the foundation of your care [5].

Because IMD99 is so rare, the path to diagnosis often requires moving beyond general labels to find the specific genetic cause. While many patients are initially told they have a more common antibody deficiency, genetic testing and detailed “immune mapping” can help confirm a diagnosis of IMD99, though genetic testing can sometimes be negative or identify a variant of uncertain significance [6]. Identifying the specific pathway that is misfiring may allow your medical team to explore a more precise, personalized approach that targets the root of the dysregulation [7].

Managing life with IMD99 requires a delicate and ongoing balancing act. Treatment typically involves a “dual strategy” where doctors replace what is missing through Immunoglobulin Replacement Therapy (IgRT) while carefully using medications to “quiet” the parts of the system that are attacking your blood cells [8]. This balance is dynamic; as one side of the immune system changes, the other often requires adjustment. This makes long-term monitoring and close communication with your immunology and hematology specialists the most important tools in your medical kit [9].

Living with this condition also means staying vigilant for warning signs, such as unusual bruising or persistent fevers, while navigating the daily challenges of chronic fatigue and medical uncertainty. While the complexity of IMD99 can feel daunting, having a clear name for the condition and a dedicated care team provides a roadmap [10]. By focusing on regular surveillance and proactive infection prevention, you and your doctors can work together to rebalance your immune system and protect your overall quality of life [11].

Quick Glossary

  • IEI: Inborn Error of Immunity, a genetic defect affecting the immune system.
  • IgRT: Immunoglobulin Replacement Therapy.
  • Trough: The lowest level of IgG in the blood, measured just before the next IgRT dose.
  • ANC: Absolute Neutrophil Count.
  • DAT/Coombs: Direct Antiglobulin Test, used to check for antibodies attached to red blood cells.
  • AIHA: Autoimmune Hemolytic Anemia.
  • ITP: Immune Thrombocytopenia.
  • PFT: Pulmonary Function Test.
  • Switched-memory B cells: Mature B cells that remember past infections.
  • CD21-low cells: A subset of B cells often elevated in immune dysregulation.

Common questions in this guide

What is Immunodeficiency 99?
Immunodeficiency 99, or IMD99, is a rare genetic disorder that affects how the immune system works. It can cause too few protective antibodies, increasing infection risk, while also causing the immune system to attack blood cells such as red blood cells or platelets.
Why can IMD99 cause both infections and autoimmune blood problems?
IMD99 can weaken antibody production, so the body may have more difficulty defending against infections. At the same time, immune regulation can be disrupted, leading the body to destroy its own red blood cells or platelets.
How is Immunodeficiency 99 diagnosed?
Diagnosis may involve genetic testing along with detailed testing that maps immune function. Genetic testing may be negative or may find a change whose significance is unclear, so doctors interpret the results together with infection history, blood counts, and immune findings.
What treatments are used for IMD99?
Treatment often combines immunoglobulin replacement therapy to provide missing antibodies with medicines that reduce immune attacks on blood cells. The balance may change over time, so immunology and hematology teams monitor infections, blood counts, treatment effects, and medication risks.
What symptoms should someone with IMD99 watch for?
Important warning signs include unusual bruising, persistent fevers, and infections that are recurrent or difficult to recover from. Patients should follow the urgent-contact plan established with their medical team, especially when symptoms are new or worsening.
Which specialists usually help manage Immunodeficiency 99?
Immunologists help evaluate immune function, antibody levels, infection risk, and replacement therapy. Hematologists help monitor and treat autoimmune problems involving blood cells, and both specialties may coordinate ongoing care.

Get notified when new evidence is published on immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.

    Westermann-Clark E, Meehan CA, Meyer AK, et al.

    Frontiers in immunology 2021; (12()):649182 doi:10.3389/fimmu.2021.649182.

    PMID: 33968040
  2. 2

    Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study.

    Tsilifis C, Speckmann C, Lum SH, et al.

    The Journal of allergy and clinical immunology 2024; (154(6)):1534-1544 doi:10.1016/j.jaci.2024.08.020.

    PMID: 39218359
  3. 3

    Prolonged Severe CD4+ Lymphocytopenia and Hypogammaglobulinemia in Patients With Evans' Syndrome: A Case Report.

    Kurokawa T, Imoto N, Muramatsu H, Shingo K

    Cureus 2024; (16(12)):e75283 doi:10.7759/cureus.75283.

    PMID: 39764316
  4. 4

    Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets.

    Cortesi M, Soresina A, Dotta L, et al.

    Frontiers in immunology 2022; (13()):846660 doi:10.3389/fimmu.2022.846660.

    PMID: 35464467
  5. 5

    Intrathymic T-cell ontogeny: Crossroad between immune competence and tolerance.

    Giardino G, Romano R, Grilli L, et al.

    The Journal of allergy and clinical immunology 2025; (156(6)):1489-1499 doi:10.1016/j.jaci.2025.10.007.

    PMID: 41138923
  6. 6

    There is no gene for CVID - novel monogenetic causes for primary antibody deficiency.

    Ramirez NJ, Posadas-Cantera S, Caballero-Oteyza A, et al.

    Current opinion in immunology 2021; (72()):176-185 doi:10.1016/j.coi.2021.05.010.

    PMID: 34153571
  7. 7

    Next-generation sequencing for inborn errors of immunity.

    Lee K, Abraham RS

    Human immunology 2021; (82(11)):871-882 doi:10.1016/j.humimm.2021.02.011.

    PMID: 33715910
  8. 8

    Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.

    Hanitsch L, Baumann U, Boztug K, et al.

    European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.

    PMID: 32845010
  9. 9

    Management of the child with primary immunodeficiency.

    Lehman HK, Khaira A, Kaur S

    Current opinion in pediatrics 2025; (37(6)):606-612 doi:10.1097/MOP.0000000000001513.

    PMID: 41190402
  10. 10

    Frequency of depression and anxiety in patients with inborn errors of immunity: a cross-sectional study.

    Wolff LJ, Witte T, Kahl KG, et al.

    BMC psychiatry 2026; (26(1)).

    PMID: 42745244
  11. 11

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994

This page is for informational purposes only and does not constitute medical advice. Ask your immunology and hematology team about your specific diagnosis, treatment plan, and urgent symptoms.